Navigation Links
Insightra Medical Inc Gains CE Mark on the Freedom(TM) Inguinal Hernia Product Range

Insightra Medical Inc Announced Today the CE Mark and Immediate Release of Their New Inguinal Hernia Product Range Freedom-I, with an Aim to Improve Surgical Outcomes and Take Significant Market Share in an Estimated $300 Million Worldwide Market.

(PRWEB) February 25, 2010 -- Insightra Medical is highly focused on bringing innovations to the field of medical devices. For the past four years they have been developing an exciting new product to address many of the complications associated with inguinal hernia such as pain, discomfort, hematoma and recurrence.

Freedom Inguinal is a next generation of inguinal prosthetics, designed to simplify the operative procedure, reduce the need for fixation and improve tissue ingrowth. A team of engineers working closely with Prof Amato, an expert of abdominal wall diseases and inventor of the device, have been refining the geometry of the implant to help absorb the forces that normally expel devices while also increasing lateral gripping forces helping to hold it in place. Although the implant can be optionally fixed in place, pre-clinical experimentation has shown that these newly developed implants remained in place with no need for point fixation.

“Eliminating suturing or tacking of inguinal implants is a very important goal,” says Prof Amato, a general surgeon from Palermo, Italy. “Many of the complications we see in hernia are a result of excessive dissection and then passing needles and suture through very delicate structures in the groin, often damaging blood vessels or nerves. Our aim was to reduce the need to fix implants in the groin.”

Historically, implants needed to be fixed in place to stop the pressure inside the abdomen from dislodging them. The focus of Freedom-I has been to design an implant that reduces the impact of the expulsion forces, like a shock absorber, so reducing the need for fixation. The unique design of the petals of the implant were developed to improve lateral grip, while protecting delicate structures such as the spermatic cord. Over 12 months of pre-clinical implantations have shown that the implant worked as designed - staying in place without fixation in all of the subjects.

But Freedom-I holds a second innovation within its unique design - improved tissue ingrowth. Detailed histological animal studies have looked at the ingrowth patterns and tissue quality with the new design of the implant. The gentle spring like motion of the implant ensures that during tissue ingrowth, the forces continuously change with the dynamic movement of the implant. This biomechanical action promotes tissue regeneration instead of the fibrotic scarring usually seen in conventional meshes. The ingrowth of elastic elements, connective tissue, new blood vessels and nerves within Freedom-I - has been experimentally demonstrated. The tissue ingrowth resembles the regeneration of the natural components of the abdominal wall.

“The ability of the implant to compress and then reopen has a marked effect on the way tissue grows inside it,” says Prof Amato. “Our experimentation has shown that we get an exceptionally high quality of tissue ingrowth starting very early on. That improved tissue structure is seen as far out as twelve months. As we predicted, the dynamic movement creates physiologic conditions that are different to static plugs or meshes. This viable, living barrier that grows in and around the implant does not suffer from the contraction and shrinkage often demonstrated with static hernia repair devices.”

Researchers hope that the elimination of fixation and the dynamic motion of the implant will translate into improved clinical outcomes. In a previous clinical trial, early hand made versions of the product were implanted in 67 patients which now have an average follow up of over four years. The results from that trial are very positive demonstrating a simplified operative procedure, decreased complication rates and, to date, no recurrences. The results of that trial are soon to be published.

Insightra Medical intends a controlled release of the product across Europe and Asia as part of a broader clinical trial to collect more outcome data.

About Insightra:
Insightra Medical Inc is a privately owned medical device company based in Irvine California. They are focused on three strategic areas – General, uro-gynecological and cardiovascular therapies.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. NTU and Insightra Medical Inc. release their first joint venture medical device
2. Insightra Medical, Inc. Gains FDA clearance for the Most Complete Range of 7Fr Intra Aortic Balloon (IAB) Catheters
3. Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing
4. MSU engineering team designs innovative medical device
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
7. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
8. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
9. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
10. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
11. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
Post Your Comments:
Related Image:
Insightra Medical Inc Gains CE Mark on the Freedom(TM) Inguinal Hernia Product Range
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: